SMSPHARMASMS Pharmaceuticals Limited
Pharma · Drug Manufacturers - General · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. It offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on SMSPHARMA — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Debt/Equity: 0.46
- • Promoter holding: 76.5%
- • Valuation vs sector: P/E 37.8 vs sector 35.5
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • Supertrend: bullish
Bull case
- • Debt/Equity: 0.46
- • Promoter holding: 76.5%
- • Valuation vs sector: P/E 37.8 vs sector 35.5
- • Price vs SMA200: above
Bear case
- • Revenue growth: 5.6% YoY
- • Profit growth: -3.5% YoY
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Revenue growth: 5.6% YoY
- • Profit growth: -3.5% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹19.66). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.